Eli Lilly Stock Gains 6% on Strong Q2 Results: Buy, Sell, or Hold?
Eli Lilly and Company stock climbed roughly 6% following the release of its robust second-quarter financial results, drawing intense scrutiny from market analysts trying to determine whether investors should buy, ... Read More